and Scientific Affairs Board of ASM. She is a former member of the National Institutes of Health Director’s Advisory Committee and a former member of the Advisory Council of the National Institute of Allergy and Infectious Diseases. She has also served as an advisor on infectious diseases and indirect costs of research to the White House Office on Science and Technology and was previously chair of the Board of Scientific Counselors of the National Center for Infectious Diseases, Centers for Disease Control and Prevention. Dr. Cassell served eight years on the Bacteriology-Mycology-II Study Section and served as its chair for three years. She serves on the editorial boards of several prestigious scientific journals and has authored over 275 articles and book chapters. She has been intimately involved in the establishment of science policy and legislation related to biomedical research and public health. Dr. Cassell has received several national and international awards and an honorary degree for her research on infectious diseases.


ELLEN WRIGHT CLAYTON is one of the preeminent scholars in the field of law and genetics. She joined the Vanderbilt faculty in 1988 and holds appointments in both the Medical School and Law School. She has numerous publications in books, medical journals, interdisciplinary journals, and law journals on the intersection of law, medicine, and public health. Professor Clayton has collaborated with faculty in the Law School, Medical School, and Sociology Department in producing interdisciplinary research. She has been an active participant in policy debates advising the National Human Genome Research Institute as well as numerous bodies concerned with the ethical conduct of research involving human subjects for many years. In addition to teaching in the Law School and Medical School, Professor Clayton is a practicing pediatrician at the Vanderbilt Medical Center. Recently she was appointed Director of the Genetics and Health Policy Center, and holds the Rosalind E.Franklin Chair in Genetics and Health Policy. Dr. Clayton obtained her undergraduate degree from Duke University, earned her M.D. from Stanford and her J.D. from Yale.


DAVID COX is Chief Scientific Officer of Perlegen Sciences Inc. Dr. Cox is an active participant in the Human Genome Project while carrying out research involving the molecular basis of human genetic disease. After receiving his B.A. and M.S. degrees from Brown University in Rhode Island, Dr. Cox obtained his M.D. and Ph.D. degrees from the University of Washington, Seattle. He then completed his Pediatric Residency at the



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement